{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:08:46Z","timestamp":1780636126459,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25JS2830100"],"award-info":[{"award-number":["25JS2830100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227130561"],"award-info":[{"award-number":["8227130561"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273853"],"award-info":[{"award-number":["82273853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574323"],"award-info":[{"award-number":["82574323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bmc.2025.118474","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:50:42Z","timestamp":1761789042000},"page":"118474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery, SAR, and molecular basis of (R)-1-((3R,4S)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-3-(3-fluorophenyl)-2-methylpropan-1-one as a novel potent analgesic"],"prefix":"10.1016","volume":"132","author":[{"given":"Xiaodi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bmc.2025.118474_bb0005","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bmc.2025.118474_bb0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mayocp.2012.08.020","article-title":"Why patients visit their doctors: assessing the most prevalent conditions in a defined American population","volume":"88","author":"St Sauver","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"42","key":"10.1016\/j.bmc.2025.118474_bb0015","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.2174\/13816128113199990362","article-title":"The \u03bc opioid receptor and ligands acting at the \u03bc opioid receptor, as therapeutics and potential therapeutics","volume":"19","author":"Spetea","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"13","key":"10.1016\/j.bmc.2025.118474_bb0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bmc.2025.118474_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.bmc.2025.118474_bb0030","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1021\/jm060521i","article-title":"Thyroid receptor ligands. 6. A high affinity \u201cdirect antagonist\u201d selective for the thyroid hormone receptor","volume":"49","author":"Koehler","year":"2006","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118474_bb0035","first-page":"826","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group. 8. 7-Alkyl-6,14-endo-ethenotetrahydro-thebaine and related compounds","volume":"1","author":"Bentley","year":"1969","journal-title":"J Chem Soc Perkin"},{"issue":"18","key":"10.1016\/j.bmc.2025.118474_bb0040","first-page":"2385","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group. XV. Ozonolysis of derivatives of 6,14-endo-ethenotetrahydrothebaine","volume":"1","author":"Bentley","year":"1969","journal-title":"J Chem Soc Perkin"},{"issue":"17","key":"10.1016\/j.bmc.2025.118474_bb0045","first-page":"2235","article-title":"Novel analgesics and molecular rearrangements in the morphine--thebaine group. XII. Derivatives of 7-amino-6,14-endo-ethenotetrahydrothebaine","volume":"1","author":"Bentley","year":"1969","journal-title":"J Chem Soc Perkin"},{"key":"10.1016\/j.bmc.2025.118474_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-025-01172-w","article-title":"Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail","author":"Breault","year":"2025","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.bmc.2025.118474_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/J354v21n01_15","article-title":"Respiratory depression with opioids","volume":"21","author":"Dahan","year":"2007","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"10","key":"10.1016\/j.bmc.2025.118474_bb0060","doi-asserted-by":"crossref","first-page":"S4-5","DOI":"10.12968\/bjon.2016.25.10.S4","article-title":"Management of opioid-induced constipation","volume":"25","author":"Prichard","year":"2016","journal-title":"Br J Nurs"},{"key":"10.1016\/j.bmc.2025.118474_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2013.09.074","article-title":"Opioid induced nausea and vomiting","volume":"722","author":"Smith","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2025.118474_bb0070","doi-asserted-by":"crossref","unstructured":"Freye E, Latasch L. [development of opioid tolerance -- molecular mechanisms and clinical consequences]. Anasthesiol Intensivmed Notfallmed Schmerzther. Jan 2003;38(1):14-26. Toleranzentwicklung unter Opioidgabe -- Molekulare Mechanismen und klinische Bedeutung doi:https:\/\/doi.org\/10.1055\/s-2003-36558.","DOI":"10.1055\/s-2003-36558"},{"issue":"6","key":"10.1016\/j.bmc.2025.118474_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.bmc.2025.118474_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.105.096032","volume":"317","author":"Bileviciute-Ljungar","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.bmc.2025.118474_bb0085","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1021\/jm00378a009","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonists in the series of (\u2212)-14-methoxy-N-methylmorphinan-6-ones","volume":"27","author":"Schmidhammer","year":"1984","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2025.118474_bb0090","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00000539-200006000-00018","article-title":"14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog","volume":"90","author":"Freye","year":"2000","journal-title":"Anesth Analg"},{"issue":"5449","key":"10.1016\/j.bmc.2025.118474_bb0095","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bmc.2025.118474_bb0100","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"20","key":"10.1016\/j.bmc.2025.118474_bb0105","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1021\/jm4010829","article-title":"Structure-activity relationships and discovery of a G protein biased \u03bc opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain","volume":"56","author":"Chen","year":"2013","journal-title":"J Med Chem"},{"issue":"7619","key":"10.1016\/j.bmc.2025.118474_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.bmc.2025.118474_bb0115","article-title":"Structure-Based Evolution of G Protein-Biased \u03bc-Opioid Receptor Agonists","volume":"61","author":"Wang","year":"2022","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.bmc.2025.118474_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107576","article-title":"Efficacy and safety of SHR8554 on postoperative pain in subjects with moderate to severe acute pain following orthopedic surgery: a multicenter, randomized, double-blind, dose-explored, active-controlled, phase II\/III clinical trial","volume":"212","author":"Zhao","year":"2025","journal-title":"Pharmacol Res"},{"issue":"625","key":"10.1016\/j.bmc.2025.118474_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis","year":"2020","journal-title":"Sci Signal"},{"issue":"19","key":"10.1016\/j.bmc.2025.118474_bb0130","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1113\/JP270822","article-title":"\u03bc opioid receptor activation hyperpolarizes respiratory-controlling K\u00f6lliker-fuse neurons and suppresses post-inspiratory drive","volume":"593","author":"Levitt","year":"2015","journal-title":"J Physiol"},{"issue":"11","key":"10.1016\/j.bmc.2025.118474_bb0135","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1021\/acs.jmedchem.4c00480","article-title":"Discovery of ITI-333, a Novel Orally Bioavailable Molecule Targeting Multiple Receptors for the Treatment of Pain and Other Disorders","volume":"67","author":"Li","year":"2024","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2025.118474_bb0140","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1021\/acs.jmedchem.4c00442","article-title":"Multitarget \u03bc-opioid receptor agonistsneuropeptide FF receptor antagonists induce potent antinociception with reduced adverse side effects","volume":"67","author":"De Neve","year":"2024","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2025.118474_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.02.034","article-title":"Flexible scaffold-based cheminformatics approach for polypharmacological drug design","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2025.118474_bb0150","article-title":"Development of 5-substituted N-Methylmorphinan-6-ones as potent opioid analgesics with improved side-effect profile","volume":"2012","author":"Schmidhammer","year":"2012","journal-title":"Int J Med Chem"},{"issue":"14","key":"10.1016\/j.bmc.2025.118474_bb0155","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.bmc.2010.06.005","article-title":"Evaluation of N-substitution in 6,7-benzomorphan compounds","volume":"18","author":"Pasquinucci","year":"2010","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2025.118474_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23030677","article-title":"Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists","volume":"23","author":"Turnaturi","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bmc.2025.118474_bb0165","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1021\/acs.jmedchem.2c01707","article-title":"Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor","volume":"66","author":"Hennessy","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118474_bb0170","doi-asserted-by":"crossref","unstructured":"Huang H, Wang W, Xu X, et al. Discovery of 3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)-N-phenylpiperidine-1-carboxamide as novel potent analgesic. Eur J Med Chem 2020;189doi:https:\/\/doi.org\/10.1016\/j.ejmech.2020.112070.","DOI":"10.1016\/j.ejmech.2020.112070"},{"issue":"2","key":"10.1016\/j.bmc.2025.118474_bb0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acschemneuro.0c00487","article-title":"Design, Synthesis, and Structure\u2013Activity Relationship Exploration of Alkyl\/Phenylalkyl Piperidine Analogues as Novel Highly Potent and Selective \u03bc Opioid Receptor Agonists","volume":"12","author":"Huang","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"13","key":"10.1016\/j.bmc.2025.118474_bb0180","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1021\/acs.jmedchem.1c00722","article-title":"Discovery, Structure\u2013Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic","volume":"64","author":"Huang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118474_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116643","article-title":"Discovery of N\u2032-benzyl-3-chloro-N-((1S,3R,4R)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)cyclohexyl)benzenesulfonamide as a novel selective KOR ligand","volume":"276","author":"Gao","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2025.118474_bb0190","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40242-024-4075-8","article-title":"Molecular mechanism of action of GPR91 agonists and antagonists: insights from molecular dynamics simulation","volume":"40","author":"Zhang","year":"2024","journal-title":"Chem Res Chin Univ"},{"key":"10.1016\/j.bmc.2025.118474_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-025-01624-5","article-title":"Uricolysis by Arthrobacter globiformis uricase: structural basis for its catalytic activity and thermostability","author":"Lv","year":"2025","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.bmc.2025.118474_bb0200","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.108.142802","article-title":"Pharmacological characterization of ATPM [(\u2212)-3-Aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed \u03ba-agonist and \u03bc-agonist\/\u2212antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior","volume":"329","author":"Wang","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.bmc.2025.118474_bb0205","first-page":"284","article-title":"Reflections on improving drug success rates with AIDD and CADD","volume":"55","author":"Baiyu","year":"2024","journal-title":"J China Pharm Univ"},{"issue":"16","key":"10.1016\/j.bmc.2025.118474_bb0210","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1039\/C5OB00288E","article-title":"Room temperature N-arylation of amino acids and peptides using copper(I) and \u03b2-diketone","volume":"13","author":"Sharma","year":"2015","journal-title":"Org Biomol Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:59:19Z","timestamp":1780635559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625004158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S0968089625004158"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118474","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery, SAR, and molecular basis of (R)-1-((3R,4S)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-3-(3-fluorophenyl)-2-methylpropan-1-one as a novel potent analgesic","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118474"}}